2005•Zhongliu fangzhi yanjiuRequires access

A Clinical Study of Combination of the Radiotherapy and Chemotherapy in the Treatment of Patients with Advanced Esophageal Cancer

Yang Hai-ming

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy of the radiotherapy combined chemotherapy in treating advanced esophageal cancer. Methods Sixty-eight cases of advanced esophageal cancer were divided into two groups randomly: thirty-six cases in the treatment group and thirty-two cases in the contrast group. The cases in the treatment group treated with the radiotherapy combined chemotherapy, and the cases in the contrast group treated with the radiotherapy simply. Results The total response rate of the treatment group and the contrast group was 88.89% and 62.5% respectively. The difference between the two groups was significant. The survival rate of 1, 2, 3 years of the treatment group and the contrast group were 63.9%,50%, 27.8% and 59.3%, 34.3%, 18.8% respectively. Conclusion Combination of the radiotherapy and chemotherapy was an effective way in the treatment of patients with advanced esophageal cancer.

About this research paper

What this paper is about

Objective To evaluate the efficacy of the radiotherapy combined chemotherapy in treating advanced esophageal cancer. Methods Sixty-eight cases of advanced esophageal cancer were divided into two groups randomly: thirty-six cases in the treatment group and thirty-two cases in the contrast group. The cases in the treatment group treated with the radiotherapy combined chemotherapy, and the cases in the contrast group treated with the radiotherapy simply. Results The total response rate of the treatment group and the contrast group was 88.89% and 62.5% respectively. The difference between the two groups was significant. The survival rate of 1, 2, 3 years of the treatment group and the contrast group were 63.9%,50%, 27.8% and 59.3%, 34.3%, 18.8% respectively. Conclusion Combination of the radiotherapy and chemotherapy was an effective way in the treatment of patients with advanced esophageal cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy of the radiotherapy combined chemotherapy in treating advanced esophageal cancer. Methods Sixty-eight cases of advanced esophageal cancer were divided into two groups randomly: thirty-six cases in the treatment group and thirty-two cases in the contrast group. The cases in the treatment group treated with the radiotherapy combined chemotherapy, and the cases in the contrast group treated with the radiotherapy simply. Results The total response rate of the treatment group and the contrast group was 88.89% and 62.5% respectively. The difference between the two groups was significant. The survival rate of 1, 2, 3 years of the treatment group and the contrast group were 63.9%,50%, 27.8% and 59.3%, 34.3%, 18.8% respectively. Conclusion Combination of the radiotherapy and chemotherapy was an effective way in the treatment of patients with advanced esophageal cancer.

Key concepts: Medicine, Radiation therapy, Esophageal cancer, Chemotherapy, Internal medicine, Significant difference, Oncology, Cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
A Clinical Study of Combination of the Radiotherapy and Chemotherapy in the Treatment of Patients with Advanced Esophageal Cancer — Research Paper | ScholarLens